Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020

Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020

Digitalization in Drug Discovery Presents Significant Growth Opportunities for Healthcare IT Companies

RELEASE DATE
12-Dec-2017
REGION
North America
Research Code: 9AB9-00-7E-00-00
SKU: LS00276-NA-MR_21260
AvailableYesPDF Download
$1,500.00
In stock
SKU
LS00276-NA-MR_21260
$1,500.00
DownloadLink
ENQUIRE NOW

Description

The growing focus of pharmaceutical companies on reducing their drug discovery spending has resulted in companies looking to adopt information technology and informatics solutions to achieve efficiency in their R&D operations. While adoption of IT solutions in clinical research and trial activities is relatively high, drug discovery digital solutions have just started to grow, with companies primarily looking at data analytics and AI-based solutions to the improve efficiency of their research operations.

As adoption of IT solutions grows and vendors develop clarity about customer requirements, the market is expected to witness a transformation in existing product landscape and available opportunities. At present, most market developments and innovations are led by small market participants and start-ups, which are also gaining strong traction from Big Pharma companies. In the near to mid-term, expected expansion plans of large healthcare IT companies are likely to drive market growth and change the overall industry landscape. Despite this, evolution of innovative small companies will continue. This translates into interesting innovations and technology-driven market dynamics.

The global pharmaceutical drug discovery IT solutions market is expected to reach $5.3 billion by 2020 at a compound annual growth rate (CAGR) of 8.9%. Medicinal chemistry solutions are likely to be the dominant IT spending category during the forecast period. The market is highly fragmented with a handful of global participants and many application-focused solution providers.

Key Features

This research publication aims to provide insights on existing and emerging growth opportunities in the global pharmaceutical drug discovery IT solutions market. It covers qualitative and quantitative market insights on overall spend of pharmaceutical companies on drug discovery IT solutions, key market segments, and their spending breakdown, adoption level of IT solutions by top 10 pharmaceutical companies in their drug discovery operations and highlights of their existing operations. The research study further delves into key market segments and associated opportunities, competitive landscape and key participants in the market.


Key Issues Addressed

  • What is the current market landscape and expected growth in the IT spend of pharmaceutical companies in their drug discovery operations?
  • What are the key long-term and short-term opportunities that can be capitalized upon by existing market players and potential entrants?
  • What is the current adoption level of drug discovery IT solutions in the pharmaceutical industry? What initiatives have been taken by Big Pharma companies?
  • What is the current competitive landscape of the market? How are different participants positioned in this segment?
  • What are the key market trends and how are they impacting the overall market landscape?

Table of Contents

Key Findings

Market Engineering Measurements

Market Engineering Measurements (continued)

Market Definition—Drug Discovery IT Solutions

Market Overview and Landscape

Scope and Segmentation

Key Questions Addressed in this Study

Market Drivers

Drivers for ICT Adoption in Drug Discovery Operations

Market Restraints

Restraints for ICT Adoption in Drug Discovery Operations

Forecast Assumptions—Global Pharmaceutical R&D IT Market

Market Engineering Measurements—Pharmaceutical R&D IT Market

Revenue Forecast—Pharmaceutical R&D IT Market

Global Pharmaceutical R&D IT Spend by Function

Global Pharmaceutical R&D IT Market—Regional Breakdown

Revenue Forecast Discussion

Forecast Assumptions––Global Drug Discovery IT Solutions Market

Market Engineering Measurements––Pharmaceutical Drug Discovery IT Solutions Market

Revenue Forecast––Pharmaceutical Drug Discovery IT Solutions Market

Pharmaceutical Drug Discovery IT Solutions Market Breakdown by Key Segments

Revenue Forecast Discussion

Global Pharmaceutical Drug Discovery IT Solutions––Key Trends and Impact on Business

Global Pharmaceutical Drug Discovery IT Solutions––Key Trends Explained

Global Pharmaceutical Drug Discovery IT Solutions––Key Trends Explained (continued)

Global Pharmaceutical Drug Discovery IT Solutions––Key Trends Explained (continued)

IT Adoption Level Across Different Functions––Drug Discovery and Clinical Development Process

IT Solutions Adoption Levels In the Pharmaceutical Industry

Key Initiatives by Big Pharmaceutical Companies

Key Initiatives by Big Pharmaceutical Companies (continued)

Key Initiatives by Big Pharmaceutical Companies (continued)

Highlights of IT Tools Adoption in Drug Discovery Applications

Highlights of IT Tool Adoption in Drug Discovery Applications (continued)

Product/Service Life Cycle Analysis of Major IT Solutions

Segments to Watch––Medicinal Chemistry Market

Segments to Watch––Genomics (NGS Informatics Market)

Segments to Watch––Genomics (Machine Learning in Genomics)

Segments to Watch––Pharmacovigilance and Drug Safety IT Solutions

Competitive Environment

Competitive Factors Assessment

Key Companies to Watch

Key Companies to Watch (continued)

3 Key Opportunities

Strategic Imperatives

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

The growing focus of pharmaceutical companies on reducing their drug discovery spending has resulted in companies looking to adopt information technology and informatics solutions to achieve efficiency in their R&D operations. While adoption of IT solutions in clinical research and trial activities is relatively high, drug discovery digital solutions have just started to grow, with companies primarily looking at data analytics and AI-based solutions to the improve efficiency of their research operations. As adoption of IT solutions grows and vendors develop clarity about customer requirements, the market is expected to witness a transformation in existing product landscape and available opportunities. At present, most market developments and innovations are led by small market participants and start-ups, which are also gaining strong traction from Big Pharma companies. In the near to mid-term, expected expansion plans of large healthcare IT companies are likely to drive market growth and change the overall industry landscape. Despite this, evolution of innovative small companies will continue. This translates into interesting innovations and technology-driven market dynamics. The global pharmaceutical drug discovery IT solutions market is expected to reach $5.3 billion by 2020 at a compound annual growth rate (CAGR) of 8.9%. Medicinal chemistry solutions are likely to be the dominant IT spending category during the forecast period. The market is highly fragmented with a handful of global participants and many application-focused solution providers.--BEGIN PROMO--

Key Features

This research publication aims to provide insights on existing and emerging growth opportunities in the global pharmaceutical drug discovery IT solutions market. It covers qualitative and quantitative market insights on overall spend of pharmaceutical companies on drug discovery IT solutions, key market segments, and their spending breakdown, adoption level of IT s

More Information
No Index No
Podcast No
Author Piyush Bansal
WIP Number 9AB9-00-7E-00-00
Is Prebook No